ZA200901521B - Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators - Google Patents
Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulatorsInfo
- Publication number
- ZA200901521B ZA200901521B ZA200901521A ZA200901521A ZA200901521B ZA 200901521 B ZA200901521 B ZA 200901521B ZA 200901521 A ZA200901521 A ZA 200901521A ZA 200901521 A ZA200901521 A ZA 200901521A ZA 200901521 B ZA200901521 B ZA 200901521B
- Authority
- ZA
- South Africa
- Prior art keywords
- oxadiazole
- receptor modulators
- acetylcholine receptor
- nicotinic acetylcholine
- thiadiazole compounds
- Prior art date
Links
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 title 1
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 title 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 title 1
- 150000004867 thiadiazoles Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200601380 | 2006-10-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200901521B true ZA200901521B (en) | 2010-06-30 |
Family
ID=40996458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200901521A ZA200901521B (en) | 2006-10-25 | 2007-10-24 | Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
Country Status (7)
| Country | Link |
|---|---|
| KR (1) | KR20090069183A (ru) |
| CN (1) | CN101553486A (ru) |
| BR (1) | BRPI0717306A2 (ru) |
| NZ (1) | NZ575354A (ru) |
| RU (1) | RU2009113451A (ru) |
| UA (1) | UA99443C2 (ru) |
| ZA (1) | ZA200901521B (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103402983B (zh) * | 2011-02-25 | 2015-12-23 | 詹森药业有限公司 | 作为α7nAChR的别构调节剂的(吡啶-4-基)苄基酰胺 |
| CN103420998A (zh) * | 2012-05-16 | 2013-12-04 | 苏州爱斯鹏药物研发有限责任公司 | 一种新型噁二唑衍生物的合成方法 |
| CN111362930B (zh) * | 2020-04-15 | 2023-02-03 | 安徽医科大学 | 一种1，2，4-噁二唑-吡啶类化合物及其应用 |
-
2007
- 2007-10-24 KR KR1020097008536A patent/KR20090069183A/ko not_active Withdrawn
- 2007-10-24 RU RU2009113451/04A patent/RU2009113451A/ru not_active Application Discontinuation
- 2007-10-24 CN CNA2007800391836A patent/CN101553486A/zh active Pending
- 2007-10-24 ZA ZA200901521A patent/ZA200901521B/xx unknown
- 2007-10-24 UA UAA200903386A patent/UA99443C2/ru unknown
- 2007-10-24 BR BRPI0717306-7A2A patent/BRPI0717306A2/pt not_active IP Right Cessation
- 2007-10-24 NZ NZ575354A patent/NZ575354A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0717306A2 (pt) | 2014-04-15 |
| KR20090069183A (ko) | 2009-06-29 |
| UA99443C2 (ru) | 2012-08-27 |
| CN101553486A (zh) | 2009-10-07 |
| RU2009113451A (ru) | 2010-11-27 |
| NZ575354A (en) | 2012-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL197397A0 (en) | Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators | |
| ZA200810836B (en) | OB fold domains | |
| ZA200809782B (en) | Novel heterocyclic compound or sal thereof and intermediate thereof | |
| GB2440663B (en) | Fiber-on-end materials | |
| GB0602192D0 (en) | Tissue-adhesive materials | |
| IL199889A0 (en) | Nicotinic acetylcholine receptor modulators | |
| ZA201308294B (en) | Heterocyclic compounds and their uses | |
| IL200605A0 (en) | Variant activin receptor polypeptides and uses thereof | |
| EP2074142A4 (en) | COMPOUNDS FOR STIMULATING THE FUNCTION OF P-GLYCOPROTEIN AND APPLICATIONS THEREOF | |
| ZA200809941B (en) | 2-anilino-4-(heterocyclic)amino-pyrimidines | |
| PL2853293T3 (pl) | Związki tioniny i ich zastosowanie | |
| GB0611115D0 (en) | Compounds and their use | |
| GB0605427D0 (en) | Materials For Binding Drugs Of Abuse | |
| IL197074A0 (en) | Thiadiazole compound and use thereof | |
| GB2450802B (en) | Fiber-on-end materials | |
| GB0619611D0 (en) | Compounds and their use | |
| ZA200806312B (en) | Ace N-domain crystal | |
| ZA200806623B (en) | Tissue-adhesive materials | |
| ZA200906568B (en) | Heterocyclic compounds and their uses | |
| HK1132629A (en) | Nuclear receptor binding agents | |
| ZA200906169B (en) | Variant activin receptor polypeptides and uses thereof | |
| GB0610888D0 (en) | Compounds and their use | |
| GB0619610D0 (en) | Compounds and their use | |
| GB0603376D0 (en) | Compounds and their use | |
| GB0616577D0 (en) | Compounds and their use |